Payer Update, February 2023

Payer Update Call the Alliance Bat Phone! by Jeff Blake, Senior Vice President Member & Community Relations At one of the breakout sessions at our Member Meeting in Nashville this month, we discussed various payer issues that our members encounter. The most common issue discussed was exclusive specialty drug carve outs to commercial specialty pharmacies, […]

Washington Update, February 2023

Washington Update HELP Copays Act Reintroduced by Johanna Gray, Advocacy Consultant I’m so pleased to share that the Help Ensure Lower Patient Copays Act (HELP Copays Act) has been reintroduced in the House! You may recall that this bill was first introduced in the last Congress to prohibit copay accumulator adjustor programs and close a […]

Legal Update, February 2023

Legal Update A New Era of Conundrums: Contracting with Related Pharmacies to Prepare for Gene Therapy by Elizabeth (Issie) Karan and Michael B. Glomb, Legal Counsels With the dawn of gene therapy, the Hemophilia Alliance is fielding more questions from member Hemophilia Treatment Centers (HTCs) about options for collaborating with in-house and/or institution pharmacies. More […]

January 2023 Newsletter

In this Issue… Notes from Joe · Isn’t it Strange? Alliance Update · Reminder: The 340B Program Recertification Period is Open! · Save the Date for Alliance Meetings for 2023! Legal Update · 340B Compliance Spotlight: The Importance of Self-Audits Washington Update · 2023 Washington Outlook Payer Update · Prepare for the Medicaid PHE Unwinding […]

Notes from Joe, January 2023

Notes from Joe Isn’t it Strange? by Joe Pugliese, President and CEO Last year we developed a five-year plan for the Alliance activities to meet the needs of our members and the patients they serve. We recently met to review our progress to date and reaffirm that our plans for 2023 targeted the key issues. […]

Alliance Update, January 2023

Alliance Update Reminder: The 340B Program Recertification Period is Open! The 2023 HRSA, OPA 340B Program Recertification period for HRSA Grantees and Indian Health Service will be January 30-February 27, 2023. Prior to being able to recertify, Authorizing Officials (AOs) and Primary Contacts (PCs) must set up a user account in the 340B Office of […]

Legal Update, January 2023

Legal Update 340B Compliance Spotlight: The Importance of Self-Audits by Issie Karan, Legal Counsel Hemophilia Treatment Centers (HTCs), which participate in the 340B Discount Drug Pricing Program as Covered Entities, must dedicate resources to appropriate oversight of their program. The hallmarks of 340B compliance include strong policies and procedures, processes, internal controls and a leadership […]

Washington Update, January 2023

Washington Update 2023 Washington Outlook by Johanna Gray, Advocacy Consultant This month has brought a new Congress with new rules and dozens of new members, a change in party control of the House of Representatives, and a new set of opportunities and challenges for HTCs and the bleeding disorders in Washington. Here’s what you need […]